MIST icon

Milestone Pharmaceuticals
MIST

Overview Fund Activity

47 hedge funds and large institutions have $203M invested in Milestone Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 2 closing their positions.

Holders
47
Holders Change
+18
Holders Change %
+62.07%
% of All Funds
0.81%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
21
Increased
9
Reduced
12
Closed
2
Calls
$11.6M
Puts
$9.09M
Net Calls
+$2.48M
Net Calls Change
+$988K

Top Buyers

1
VA
1
VR Adviser
New York
$22.3M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$10.3M
3
GPP
3
Great Point Partners
Connecticut
$6.2M
4
PBA
4
Paradigm Biocapital Advisors
New York
$5.83M
5
Citadel Advisors
5
Citadel Advisors
Florida
$5.49M

Top Sellers

1
BC
1
Boxer Capital
California
$6.42M
2
NHAS
2
Novo Holdings A/S
Denmark
$18.4M
3
IC
3
Ikarian Capital
Texas
$7.86M
4
Millennium Management
4
Millennium Management
New York
$8.58M
5
PVI
5
Pura Vida Investments
New York
$5.48M
Name Market Value Shares Shares
Change 		Shares
Change %
PI
51
PEAK6 Investments
Illinois
– – – –
CFGS
52
Concourse Financial Group Securities
Alabama
– – – –
BlackRock
53
BlackRock
New York
$0 5 +5 New
1 2
3